Frank H. Laukien - Aug 8, 2023 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: PRESIDENT & CEO, Director, 10%+ Owner
Signature: /s/ Michael Simone
Stock symbol: BRKR
Transactions as of: Aug 8, 2023
Transactions value $: -$346,768
Form type: 4
Date filed: 8/10/2023, 05:09 PM
Previous filing: Aug 10, 2023
Next filing: Aug 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Options Exercise	$2.11M	+44.2K	+0.12%	$47.85	38.3M	Aug 8, 2023	Direct
transaction	BRKR	Common Stock	Sale	-$2.46M	-37.9K	-0.1%	$64.81	38.2M	Aug 8, 2023	Direct	F1
holding	BRKR	Common Stock						1.05M	Aug 8, 2023	By Former Spouse
holding	BRKR	Common Stock						337K	Aug 8, 2023	By Son
holding	BRKR	Common Stock						337K	Aug 8, 2023	By Daughter
holding	BRKR	Common Stock						202K	Aug 8, 2023	As UTMA Custodian for Son
holding	BRKR	Common Stock						71.7K	Aug 8, 2023	As UTMA Custodian for Son
holding	BRKR	Common Stock						492	Aug 8, 2023	By Former Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRKR	Stock Option (Right to Purchase)	Options Exercise	$0	-44.2K	-100%	$0.00^*	0	Aug 8, 2023	Common Stock	44.2K	$47.85	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date.